You are here:
Proceeds to Gavi, the Vaccine Alliance from donor contributions & pledges (2011-2015) as of 30 June 2015
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Contributions comprise direct contributions already received by GAVI from donors, contributions made to IFFIm and the AMC donor contributions to the World Bank. All 2000-2014 direct, Matching Fund, and AMC contributions are recorded in US dollars at the actual exchange rates for the day of cash received. Direct Contribution and Matching Fund pledges for years 2015 and beyond are expressed in US dollar equivalents using the forecast rates from Bloomberg as at 30 June 2015; for the year 2015: using the forecast for Q4 2015; and for the years 2016 onwards: using an average of the available yearly forecast rates. Pledges for these years for which contributions have already been received are expressed in US dollar equivalents using the exchange rates on the dates of receipt. Non-US dollar pledges for these years that have been hedged to mitigate currency risk exposure are expressed in US dollar equivalents using the exchange rates stated in the hedge agreements.
All 2000-2014 IFFIm contributions are recorded in US dollars equivalents using the exchange rates at the time of signing the respective donor grant agreements. Unsigned non-US dollar IFFIm pledges are expressed in US dollar equivalents using an average of the available yearly forecast rates from Bloomberg. These contributions have not been reduced by a notional 3% provision to allow for any potential reduction arising from the High Level Financing Condition of the IFFIm Finance Framework Agreement.
Brazil has an increasing role as a political and economic actor in developed and developing countries. Brazil has a long standing commitment to ensuring access to medicines and vaccines at the domestic, regional and international level. The Ministry of Health strategy for 2012-2015 addresses 5 pillars. These include the promotion of Brazil’s science and technology complex; Brazilian presence in multilateral health forums; strengthening of regional health integration; strengthening of international humanitarian health support; improved management of Brazilian engagement in international health issues. Brazil’s state owned vaccine manufacturer Bio-Manguinhos is a supplier of yellow fever vaccine to Gavi.
In 2006, Brazil pledged USD 20 million over 20 years to IFFIm. Legislative approval was granted by Congress on 31 May 2011 to allow Brazil to make contributions to Gavi. Brazil is currently finalising the pledge agreement.
Contributions and pledges in total:
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2015
modal window here